Add to Calendar Hypertension, Lipids, and Approaches to CV Pharmacologic Risk Reduction 2023 10/20/2023 8:00:00 AM 10/20/2023 1:50:00 PM America/New_York For More Details: https://upenn.cloud-cme.com/PreventiveCardiology2023 Description: CVD is the leading cause of death in the US. Hypertension and diabetes are among the foremost risk factors for the development of CVD, stroke, peripheral artery disease, and heart attack. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the new guidelines for hypertension, DM and CKD and will dis... Virtual false MM/DD/YYYY


Date & Location
Friday, October 20, 2023, 8:00 AM - 1:50 PM, Virtual

Course Overview
CVD is the leading cause of death in the US. Hypertension and diabetes are among the foremost risk factors for the development of CVD, stroke, peripheral artery disease, and heart attack. This program will provide an overview of recent advances that target the underlying pathophysiology of cardiovascular disease. The focus of the program will be on the new guidelines for hypertension, DM and CKD and will discuss the advances in pharmacotherapeutics in these fields.

Target Audience
Specialties - FAMILY MEDICINE, FAMILY MEDICINE - Geriatric Medicine, INTERNAL MEDICINE, INTERNAL MEDICINE - Advanced Heart Failure and Transplant Cardiology, INTERNAL MEDICINE - Clinical Cardiac Electrophysiology, INTERNAL MEDICINE - Endocrinology, Diabetes and Metabolism, INTERNAL MEDICINE - Geriatric Medicine, INTERNAL MEDICINE - Interventional Cardiology, INTERNAL MEDICINE - Nephrology, INTERNAL MEDICINE - Sports Medicine, OBSTETRICS AND GYNECOLOGY, OBSTETRICS AND GYNECOLOGY - Maternal and Fetal Medicine, PREVENTIVE MEDICINE - Clinical Informatics, PUBLIC HEALTH AND GENERAL PREVENTIVE MEDICINE

Learning Objectives

After completing this activity, participants should be able to:


  1. Select appropriate medications to reduce adverse cardiovascular outcomes in high-risk and vulnerable populations
  2. Identify appropriate blood pressure goals and management in several special patient populations
  3. Review the controversies regarding the appropriate treatment of, and management of, pregnant patients at risk for CVD.
  4. Provide the best screening and treatment options for hypertension in young patients with hyperlipidemia
  5. Apply appropriate pharmacologic and non-pharmacologic approaches to cardiovascular risk prevention

Registration
A VIRTUAL PRESENTATION
Hypertension, Lipids, and Approaches to CV Pharmacologic Risk Reduction – What’s New in 2023 will be live-streamed on Friday, October 20, 2023. Attendees will be required to sign into the conference using your first name, last name and email address in order to be marked as attended and receive credit.
 
REGISTRATION FEES
Hypertension, Lipids, and Approaches to CV Pharmacologic Risk Reduction – What’s New in 2023 is $50 for all attendees. Penn Medicine employees, faculty, staff & students, Drexel University faculty, staff & students and Jefferson University residents, fellows & students may register at a reduced rate of $10. Penn Medicine Departments of Medicine and Cardiovascular faculty, staff, residents & students should use code PENNBP23 to receive complimentary registration.
 
Need to Register by Mail? Please note: mailed registrations can take up to 5-10 business days before they are received. We are experiencing longer delays in receiving mail due to the U.S. postal service issues. We encourage all attendees to register online. See the registration form for mailing instructions. All registrations will be confirmed by email as long as your registration is received no later than October 18, 2023. BE SURE TO CHECK YOUR SPAM BOX FOR EMAILS REGARDING THIS CONFERENCE.

Accreditation
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
DESIGNATION OF CREDIT
Physicians: Penn Medicine designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 
Nurses: This program provides 4.75 NPDS.
 
Pharmacists: This knowledge-based activity is approved for 4.75 ACPE contact hours of continuing pharmacy education credit.
UAN JA0000324-0000-23-046-L04-P
 
Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 4.75 Category 1 credits for completing this activity.

Credits
AMA PRA Category 1 Credits™ (4.75 hours), ABIM MOC Part 2 (4.75 hours), ABS CC (4.75 hours), ABS CC SAM (4.75 hours), ACPE (4.75 hours), NCPD Hours (ANCC) (4.75 hours), Non-Physician Attendance / Participation (4.75 hours)

Additional Information
CANCELLATION/REFUND POLICY
In order to process refunds for course withdrawals, cancellations must be received in writing by October 13, 2023 and are subject to a $15.00 service charge. No refunds will be issued thereafter. 
 
In the event of cancellation or postponement, the University will refund registration fees but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines and travel agencies.